Literature DB >> 15610032

Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas.

Rolf B Andersen1, Henrik Karring, Torben Møller-Pedersen, Zuzana Valnickova, Ida B Thøgersen, Chris J Hedegaard, Torsten Kristensen, Gordon K Klintworth, Jan J Enghild.   

Abstract

Mutations in the TGFBI (BIGH3) gene that encodes for transforming growth factor beta induced protein (TGFBIp) are the cause of several phenotypically different corneal dystrophies. While the genetics of these protein misfolding diseases are well documented, relatively little is known about this extracellular matrix protein itself. In this study, we have purified TGFBIp from normal human and porcine corneas using nondenaturing conditions and standard chromatography techniques. The two homologues were shown to be monomers, and we did not find evidence for posttranslational additions. The C-terminal of both human and porcine TGFBIp is truncated predominantly after the integrin binding sequence Arg(642)-Gly(643)-Asp(644) (RGD). However, using an antibody against the C-terminal fragment (residues 648-683), we also detected a small amount of full-length TGFBIp in corneal extracts. Approximately 60% of TGFBIp was covalently associated with insoluble components of the extracellular matrix in both human and porcine corneas through a disulfide bridge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610032     DOI: 10.1021/bi048589s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

Review 1.  Focus on molecules: Transforming growth factor beta induced protein (TGFBIp).

Authors:  Kasper Runager; Jan J Enghild; Gordon K Klintworth
Journal:  Exp Eye Res       Date:  2007-12-23       Impact factor: 3.467

2.  Polymorphic fibrillation of the destabilized fourth fasciclin-1 domain mutant A546T of the Transforming growth factor-β-induced protein (TGFBIp) occurs through multiple pathways with different oligomeric intermediates.

Authors:  Maria Andreasen; Søren B Nielsen; Kasper Runager; Gunna Christiansen; Niels Chr Nielsen; Jan J Enghild; Daniel E Otzen
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

3.  Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp.

Authors:  Kasper Runager; Rajiv V Basaiawmoit; Taru Deva; Maria Andreasen; Zuzana Valnickova; Charlotte S Sørensen; Henrik Karring; Ida B Thøgersen; Gunna Christiansen; Jarl Underhaug; Torsten Kristensen; Niels Chr Nielsen; Gordon K Klintworth; Daniel E Otzen; Jan J Enghild
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

4.  Matrix metalloproteinase 9 (MMP-9)-dependent processing of βig-h3 protein regulates cell migration, invasion, and adhesion.

Authors:  Yeon Hyang Kim; Hyung-Joo Kwon; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

Review 5.  Periostin and TGF-β-induced protein: Two peas in a pod?

Authors:  Deane F Mosher; Mats W Johansson; Mary E Gillis; Douglas S Annis
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-08-10       Impact factor: 8.250

6.  Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging.

Authors:  Henrik Karring; Kasper Runager; Zuzana Valnickova; Ida B Thøgersen; Torben Møller-Pedersen; Gordon K Klintworth; Jan J Enghild
Journal:  Exp Eye Res       Date:  2009-09-26       Impact factor: 3.467

7.  The insoluble TGFBIp fraction of the cornea is covalently linked via a disulfide bond to type XII collagen.

Authors:  Kasper Runager; Gordon K Klintworth; Henrik Karring; Jan J Enghild
Journal:  Biochemistry       Date:  2013-04-15       Impact factor: 3.162

8.  C-terminal fragment of transforming growth factor beta-induced protein (TGFBIp) is required for apoptosis in human osteosarcoma cells.

Authors:  Rogelio Zamilpa; Rajesha Rupaimoole; Clyde F Phelix; Maria Somaraki-Cormier; William Haskins; Reto Asmis; Richard G LeBaron
Journal:  Matrix Biol       Date:  2009-06-06       Impact factor: 11.583

9.  Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene.

Authors:  Henrik Karring; Zuzana Valnickova; Ida B Thøgersen; Chris J Hedegaard; Torben Møller-Pedersen; Torsten Kristensen; Gordon K Klintworth; Jan J Enghild
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

10.  Denaturation and solvent effect on the conformation and fibril formation of TGFBIp.

Authors:  Heather L Grothe; Morgan R Little; Angela S Cho; Andrew J W Huang; Ching Yuan
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.